Choline and Nonalcoholic Fatty Liver Disease (NAFLD): What Does the Framingham Heart Study Show?

Choline is an essential nutrient needed for, among other things, synthesizing cell membrane phospholipids, producing the neurotransmitter acetylcholine, and — particularly relevant here — manufacturing VLDL lipoproteins, the particles that transport fat out of the liver to the rest of the body. Without enough choline, the liver loses its ability to efficiently "export" excess fat, which leads to fat accumulating directly inside liver cells.

This isn't purely a theoretical hypothesis — classic feeding experiments in humans, conducted back in the 1990s and 2000s, showed that people fed a low-choline diet developed fatty liver and liver cell damage (measured by liver enzyme levels) within just a few weeks, which resolved once adequate choline intake was restored. Nonalcoholic fatty liver disease (NAFLD) is now one of the most common chronic liver diseases worldwide, strongly linked to obesity and insulin resistance — but the role of choline itself in this context was long treated as a biochemical curiosity rather than a practical dietary topic.

A recent analysis of data from the Framingham Heart Study, one of the longest-running cohort studies in the world, revisited this question directly: does the amount of choline consumed in everyday diet matter for NAFLD risk in the general population, not just under extreme experimental deficiency conditions.

This disconnect between choline itself and eggs as its carrier is one of the most interesting elements of this analysis. It suggests that the overall pattern of choline intake from various dietary sources matters, rather than mechanically increasing intake of one specific choline-rich food — eggs deliver choline but also carry other components (cholesterol, fats) that may partly mask or offset a potential benefit in population-level analyses.

An earlier analysis of a large cohort of patients with already-diagnosed, biopsy-confirmed NAFLD provides additional, complementary context — this time not about risk of developing the disease, but about disease severity in people who already have it.

This narrowing of the effect to a specific subgroup — postmenopausal women — is significant and shouldn't be overlooked. A likely explanation is that estrogen supports the body's own (endogenous) choline synthesis, and after menopause, when estrogen levels drop, dietary choline needs may genuinely increase — making this group particularly sensitive to inadequate intake of this nutrient.

The liver removes excess fat mainly by packaging it into VLDL (very low-density lipoprotein) particles and sending them into the bloodstream. Building the membrane surrounding a VLDL particle requires phosphatidylcholine, a phospholipid synthesized using choline. When choline is lacking, the liver can't produce enough VLDL particles, and fat, instead of leaving the liver, starts accumulating inside it.

The body can synthesize small amounts of choline on its own in the liver (via an enzyme partly dependent on estrogen), but for most people this endogenous production isn't enough to cover total needs — which is why choline is classified as a "conditionally essential" nutrient: the body needs a regular dietary supply, and internal production is only a supplement, not a full substitute.

This distinction has practical significance: choline occurs not only in eggs but also in meat, fish, poultry, legumes, and some cruciferous vegetables — a varied diet supplying choline from multiple sources is likely a more sensible approach than focusing narrowly on one food in hopes of protecting the liver.

The richest dietary sources of choline include egg yolks, liver, meat, fish, poultry, and to a lesser extent plant foods such as soy, broccoli, Brussels sprouts, and some nuts. It's worth noting that a food's choline content alone doesn't mean eating it automatically translates into a measurable health benefit in population studies — the Framingham analysis discussed here demonstrated this directly with eggs, which despite their high choline content showed no independent association with NAFLD risk.

Choline rarely comes up in conversations about liver health, despite a well-documented mechanism and a growing body of population data pointing to its relevance. What stands out most about this topic is the surprising lack of an independent egg effect — a reminder that a single nutrient rarely acts in isolation from the overall dietary context and the food it's found in.